None
SEDAR Interim Financial Statements

OPTI · Price
[
{
"companyName": "Optimi Health Corp.",
"reportingPeriodEnd": "2025-12-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cashAndCashEquivalents": 491750,
"accountsReceivable": 118852,
"inventory": 310388,
"prepaidsAndAdvances": 190116,
"totalCurrentAssets": 1111106,
"deposits": 17548,
"deferredFinancingCosts": 807936,
"plantAndEquipment": 12128382,
"rightOfUseAssets": 171231,
"totalAssets": 14236203,
"accountsPayableAndAccruedLiabilities": 1549202,
"dueToRelatedParties": 917869,
"deferredRevenue": 207759,
"currentPortionOfLeaseLiabilities": 27426,
"currentPortionOfLoansPayable": 2916000,
"convertibleDebentures": 3450000,
"totalCurrentLiabilities": 9068256,
"leaseLiability": 150934,
"totalLiabilities": 9219190,
"shareCapital": 31691943,
"reserves": 1636858,
"accumulatedDeficit": -28311788,
"totalShareholdersEquity": 5017013,
"totalLiabilitiesAndShareholdersEquity": 14236203,
"cashPerShare": 0.0051,
"workingCapitalPerShare": -0.0410
},
"incomeStatement": {
"revenue": 0,
"costOfSales": 0,
"grossMargin": 0,
"advertisingPromotionAndPublicRelations": 1949,
"amortizationAndDepreciation": 264749,
"bankChargesAndInterest": 278791,
"consulting": 279193,
"consumablesSuppliesAndOverhead": 39016,
"insurance": 56592,
"investorRelations": 184670,
"officeRentAndAdministration": 32313,
"professionalFees": 30671,
"researchAndDevelopment": 48495,
"shareBasedCompensation": 327,
"shipping": 7629,
"transferAgentAndFilingFees": 59471,
"travelAndAccommodation": 11435,
"wagesAndBenefits": 264087,
"totalExpenses": 1559388,
"interestAndOtherIncome": 5413,
"lossAndComprehensiveLossForThePeriod": 1553975,
"lossPerShareBasicAndDiluted": -0.02,
"weightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": 96638169
},
"cashFlowStatement": {
"netLossForTheYear": -1553975,
"amortizationAndDepreciation": 264749,
"shareBasedCompensation": 327,
"loanAccretion": 31500,
"leaseInterest": 6841,
"changesInAccountsReceivable": -23798,
"changesInInventory": 0,
"changesInDeferredRevenue": 0,
"changesInPrepaidsAndAdvances": 85604,
"changesInDueToRelatedParty": 393543,
"changesInAccountsPayableAndAccruedLiabilities": 158222,
"cashUsedInOperatingActivities": -636987,
"plantAndEquipmentExpenditures": -3428,
"cashUsedInInvestingActivities": -3428,
"subscriptionsReceivedInAdvance": 0,
"shareIssueCosts": 0,
"paymentOfLeaseObligations": -12900,
"cashProvidedByFinancingActivities": -12900,
"changeInCashAndCashEquivalentsDuringThePeriod": -653315,
"cashAndCashEquivalentsBeginningOfPeriod": 1145065,
"cashAndCashEquivalentsEndOfPeriod": 491750
},
"investmentsAndOtherAssets": [
{
"type": "Subsidiary",
"description": "Optimi Labs Inc.",
"ownershipPercentage": 100,
"value": null,
"notes": "100% ownership interest"
},
{
"type": "Subsidiary",
"description": "Optimi Nutraceuticals Corp.",
"ownershipPercentage": 100,
"value": null,
"notes": "100% ownership interest"
},
{
"type": "Term Deposit",
"description": "Term deposit – prime – 2% Demand",
"ownershipPercentage": null,
"value": 5000,
"notes": "Cash equivalent"
}
],
"shareStructure": {
"authorizedShares": "Unlimited",
"issuedShares": 96638169,
"classesOfShares": ["Common shares without par value"],
"warrants": [
{
"number": 100000,
"exercisePrice": 0.5,
"expiryDate": "2026-08-04"
},
{
"number": 100000,
"exercisePrice": 0.5,
"expiryDate": "2026-08-29"
},
{
"number": 100000,
"exercisePrice": 0.5,
"expiryDate": "2026-11-01"
},
{
"number": 758350,
"exercisePrice": 0.4,
"expiryDate": "2026-02-23"
},
{
"number": 333334,
"exercisePrice": 0.4,
"expiryDate": "2026-05-10"
},
{
"number": 908316,
"exercisePrice": 0.4,
"expiryDate": "2026-05-29"
},
{
"number": 898333,
"exercisePrice": 0.4,
"expiryDate": "2026-08-15"
},
{
"number": 658334,
"exercisePrice": 0.4,
"expiryDate": "2027-01-24"
},
{
"number": 400000,
"exercisePrice": 0.25,
"expiryDate": "2027-07-17"
}
],
"options": [
{
"number": 40000,
"exercisePrice": 0.6,
"expiryDate": "2026-01-26"
},
{
"number": 1925000,
"exercisePrice": 1.5,
"expiryDate": "2026-05-06"
},
{
"number": 50000,
"exercisePrice": 1.5,
"expiryDate": "2026-01-31"
},
{
"number": 10000,
"exercisePrice": 0.65,
"expiryDate": "2028-03-29"
},
{
"number": 100000,
"exercisePrice": 0.65,
"expiryDate": "2028-04-26"
},
{
"number": 100000,
"exercisePrice": 0.65,
"expiryDate": "2028-11-01"
},
{
"number": 15000,
"exercisePrice": 0.35,
"expiryDate": "2026-01-31"
},
{
"number": 700000,
"exercisePrice": 0.165,
"expiryDate": "2028-08-20"
},
{
"number": 600000,
"exercisePrice": 0.2,
"expiryDate": "2028-08-20"
},
{
"number": 600000,
"exercisePrice": 0.3,
"expiryDate": "2028-08-20"
}
],
"rightsConvertibleInstruments": "Convertible debentures convertible at $0.15 per share"
},
"managementCompensation": {
"currency": "CAD",
"periods": {
"periodEndedDecember312025": {
"consultingFees": 142645
},
"periodEndedDecember312024": {
"consultingFees": 161234
}
},
"namedIndividuals": [],
"otherRelatedPartyTransactions": [
{
"counterparty": "BC Green Pharmaceuticals Inc.",
"description": "Lease agreement for industrial land (Princeton Facilities)",
"amount": 4300,
"period": "Monthly"
},
{
"counterparty": "Company controlled by a director",
"description": "Loan principal",
"amount": 1000000,
"period": "Outstanding as of Dec 31, 2025"
},
{
"counterparty": "Two companies controlled by directors",
"description": "Convertible debenture principal",
"amount": 3450000,
"period": "Outstanding as of Dec 31, 2025"
}
]
},
"subsequentEvents": [
{
"eventDate": null,
"description": "105,000 stock options expired unexercised",
"impactValue": null
},
{
"eventDate": null,
"description": "Granted 850,000 stock options with an exercise price of $0.50 and a term of 5 years. These options vest one quarter on the grant date and one quarter every year thereafter.",
"impactValue": null
},
{
"eventDate": null,
"description": "Granted 555,000 restricted share rights that vest one quarter on the grant date and one quarter every year thereafter.",
"impactValue": null
},
{
"eventDate": null,
"description": "In the process of completing an initial public offering of its common shares on the Nasdaq Capital Market under the symbol “OPTH”.",
"impactValue": null
}
]
}
]
More from Optimi Health Corp
Jun 29, 2026 · 09:00